Shoulder Innovations, Inc.

SI Healthcare Medical Devices

Shoulder Innovations, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $47.3 million, up 49.6% from fiscal 2024. In the quarter to June 2026, revenue grew 56.0%, EPS grew 99.7%, free cash flow fell 52.4% and total debt was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.

18.09 0.28 −1.52%
Market cap
$382.4M
P/E
0.0×
Fwd P/E
−8.4×
Dividend yield
—
F-score
n/a
Altman Z
2.53
Beneish M
−2.42
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+5 more quarters

P/S ratio
7.00 5.57 2.62 4.23
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(56.89) (24.28) (14.12) (19.96)
P/B ratio
3.38 2.26 0.88 1.15
Price to Tangible BV
3.38 2.26 0.88 1.16
EV/Sales
5.60 3.83 0.31 1.20
EV/EBITDA
0.00 0.00 0.00 0.00
EV/Operating CF
(9.07) (5.99) (0.51) (2.09)
EV/FCF
(7.14) (4.72) (0.41) (1.65)
Quick Ratio
8.56 9.65 9.34 9.61
Current Ratio
10.71 11.81 11.07 11.09
Net Debt/EBITDA
9.51 12.01 14.67 18.18
Debt/Assets
9.74% 9.33% 8.78% 8.35%
Debt/Equity
0.12 0.11 0.11 0.10
Asset Turnover
0.52 0.67 0.56 0.45
Operating CF/Net income
0.73 1.47 1.13 0.98
Capex/Depreciation
(1.82) (2.31) (2.19) (3.10)
Interest Coverage
14.91 20.59 14.38 (97.96)
Research and Development Expense of Revenue
19.74% 22.47% 22.32% 12.97%
Selling, General and Administrative Expense of Revenue
116.95% 108.98% 113.35% 128.25%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
6.29% 4.35% 2.64% 2.53%
Graham Net Nets
0.26 0.39 1.03 0.80
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(9.47%) (1,149.07%) (1,529.23%) (2,283.65%)
Free Cash Flow Yield
(11.19%) (14.59%) (29.04%) (17.14%)
Revenue per Share
0.83 0.81 1.66 0.86
Operating CF per Share
(0.36) (0.60) (1.01) (0.63)
Capex per Share
(0.10) (0.13) (0.26) (0.21)
Free Cash Flow per Share
(0.46) (0.73) (1.28) (0.84)
Cash per Share
4.77 5.26 14.33 10.09
Shareholders Equity per Share
6.00 6.44 16.23 10.87
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
6.00 6.44 16.23 10.87
Free Cash Flow
(9.55) (15.09) (11.06) (11.37)
Working Capital
124.58 133.44 142.97 151.59
Capital Expenditures
(2.16) (2.73) (2.28) (2.81)
Net Current Asset Value
109.73 118.43 128.01 136.68
EV/EBIT
0.00 0.00 0.00 0.00
Capex to Sales
0.13 0.16 0.16 0.24
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
8.88 7.83 — —
Average Payables
5.99 5.39 — —
Average Inventory
20.00 17.89 — —
Average Assets
114.92 80.18 84.95 88.88
Average Common Equity
23.06 39.16 — —

Fold the line items

Columns are period end dates